We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
MOUNJARO Eli Lilly Australia Pty Ltd
Product name
MOUNJARO
Sponsor
Accepted date
Feb-2025
Active ingredients
tirzepatide
Proposed indication
For the treatment of symptomatic chronic heart failure.
Application type
C (new indication)
Publication date
Feb-2025